Global Peptides Diagnostics Market - Forecasts to 2027

According to a new market research report published by Global Market Estimates, the Global Peptides Diagnostics Market will grow at a CAGR value of 9.6% during the forecast period. The ability of peptide diagnostics to recognize microbial pathogens by using antigenic synthetic peptides in molecular and genomic assays, as well as the rapid growth of peptide-based diagnostic systems for imaging techniques, such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET) are significantly adding to market growth.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Peptides Diagnostics Market - Forecast to 2027" https://www.globalmarketestimates.com/market-report/peptides-diagnostics-market-3737

 Key Market Insights

·         The non-imaging diagnostics segment is expected to be the fastest growing segment in the Peptides Diagnostics market from 2022 to 2027 as per the type outlook

·         The epitopes segment is expected to be the fastest growing segment in the Peptides Diagnostics market from 2022 to 2027 as per the usage modality outlook

·         The government & academic research institutes segment is expected to be the largest segment in the Peptides Diagnostics market from 2022 to 2027 as per the end-use outlook

·         North America (the United States, Canada, and Mexico) will have a dominant share in the global Peptides Diagnostics market from 2022 to 2027

·         Bachem AG, Alpha Diagnostics, Creative Biolabs, Antagene, Inc., Pepscan, Creative Diagnostics, Quanterix, Inc, among others are the key players in the global peptides diagnostics market

Type Outlook (Revenue, USD Billion, 2022 - 2027)

·         Non-Imaging Diagnostics

o   ELISA

o   Microarray Technology

o   Biosensors

o   Microfluidics

o   Others

·         Imaging Diagnostics

Usage Modality Outlook (Revenue, USD Billion, 2022 - 2027)

·         Biomarkers

·         Epitopes

End-Use Outlook (Revenue, USD Billion, 2022 - 2027)

·         Pharmaceutical and Biopharmaceutical Companies

·         Government & Academic Research Institutes

Regional Outlook (Revenue, USD Billion, 2022-2027)

North America                                                                                 

• The U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA

Middle East & Africa

• Saudi Arabia
• UAE
• Rest of MEA

 

Contact: Yash Jain

Email address: yash.jain@globalmarketestimates.com

Phone Number: +16026667238